Birdwatch Note
2024-10-04 00:32:05 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
William Makis has no medical license and does not treat patients. Fenbendazole treats parasitic infections in animals, and there is no proof it can cure cancer in humans. https://www.politifact.com/factchecks/2023/feb/20/facebook-posts/no-proof-dog-deworming-drug-fenbendazole-can-cure/ https://www.logicallyfacts.com/en/fact-check/false-no-evidence-to-prove-animal-deworming-drug-fenbendazole-can-cure-cancer https://factcheck.afp.com/doc.afp.com.33DM73U https://fullfact.org/health/fenbendazole-no-evidence-cancer-cure/ https://healthfeedback.org/claimreview/lack-clinical-evidence-dog-dewormer-fenbendazole-cures-cancer/ https://jssbarristers.ca/rules/makis-v-college-of-physicians-and-surgeons-of-alberta-complaint-review-committee/
Written by 2A6B630D0AEA2ACC36E2189A989B042C8F44788D5C6526EF4EAC8856A79A73D8
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1841929008285409627
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1841999696677498881
- noteId - 1841999696677498881
- participantId -
- noteAuthorParticipantId - 2A6B630D0AEA2ACC36E2189A989B042C8F44788D5C6526EF4EAC8856A79A73D8
- createdAtMillis - 1728001925044
- tweetId - 1841929008285409627
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- William Makis has no medical license and does not treat patients. Fenbendazole treats parasitic infections in animals, and there is no proof it can cure cancer in humans. https://www.politifact.com/factchecks/2023/feb/20/facebook-posts/no-proof-dog-deworming-drug-fenbendazole-can-cure/ https://www.logicallyfacts.com/en/fact-check/false-no-evidence-to-prove-animal-deworming-drug-fenbendazole-can-cure-cancer https://factcheck.afp.com/doc.afp.com.33DM73U https://fullfact.org/health/fenbendazole-no-evidence-cancer-cure/ https://healthfeedback.org/claimreview/lack-clinical-evidence-dog-dewormer-fenbendazole-cures-cancer/ https://jssbarristers.ca/rules/makis-v-college-of-physicians-and-surgeons-of-alberta-complaint-review-committee/
Note Ratings
rated at | rated by | |
2024-10-04 17:03:49 -0500 | Rating Details | |
2024-10-04 17:03:35 -0500 | Rating Details | |
2024-10-04 14:57:31 -0500 | Rating Details | |
2024-10-04 13:58:03 -0500 | Rating Details | |
2024-10-04 13:28:26 -0500 | Rating Details | |
2024-10-04 13:14:54 -0500 | Rating Details | |
2024-10-04 13:13:12 -0500 | Rating Details | |
2024-10-04 12:46:48 -0500 | Rating Details | |
2024-10-04 12:44:30 -0500 | Rating Details | |
2024-10-04 12:39:25 -0500 | Rating Details | |
2024-10-04 12:39:12 -0500 | Rating Details | |
2024-10-04 12:23:57 -0500 | Rating Details | |
2024-10-04 12:21:29 -0500 | Rating Details | |
2024-10-04 12:05:19 -0500 | Rating Details | |
2024-10-04 11:09:30 -0500 | Rating Details | |
2024-10-04 10:32:38 -0500 | Rating Details | |
2024-10-04 10:28:42 -0500 | Rating Details | |
2024-10-04 10:14:08 -0500 | Rating Details | |
2024-10-04 09:50:52 -0500 | Rating Details | |
2024-10-04 09:42:50 -0500 | Rating Details | |
2024-10-04 09:31:31 -0500 | Rating Details | |
2024-10-04 09:26:11 -0500 | Rating Details | |
2024-10-04 09:16:18 -0500 | Rating Details | |
2024-10-04 09:05:48 -0500 | Rating Details | |
2024-10-04 09:00:48 -0500 | Rating Details | |
2024-10-04 08:19:08 -0500 | Rating Details | |
2024-10-04 08:01:24 -0500 | Rating Details | |
2024-10-04 07:58:20 -0500 | Rating Details | |
2024-10-04 07:16:16 -0500 | Rating Details | |
2024-10-04 07:12:17 -0500 | Rating Details | |
2024-10-04 06:55:08 -0500 | Rating Details | |
2024-10-04 06:52:44 -0500 | Rating Details | |
2024-10-04 06:35:10 -0500 | Rating Details | |
2024-10-04 06:30:45 -0500 | Rating Details | |
2024-10-04 06:28:48 -0500 | Rating Details | |
2024-10-04 06:19:01 -0500 | Rating Details | |
2024-10-04 06:09:13 -0500 | Rating Details | |
2024-10-04 04:10:21 -0500 | Rating Details | |
2024-10-04 04:07:57 -0500 | Rating Details | |
2024-10-04 04:01:00 -0500 | Rating Details | |
2024-10-04 02:58:14 -0500 | Rating Details | |
2024-10-04 02:49:55 -0500 | Rating Details | |
2024-10-04 02:42:54 -0500 | Rating Details | |
2024-10-04 02:05:00 -0500 | Rating Details | |
2024-10-04 01:59:58 -0500 | Rating Details | |
2024-10-04 01:58:05 -0500 | Rating Details | |
2024-10-04 01:55:48 -0500 | Rating Details | |
2024-10-04 01:01:38 -0500 | Rating Details | |
2024-10-03 23:45:57 -0500 | Rating Details | |
2024-10-03 23:30:12 -0500 | Rating Details | |
2024-10-03 23:17:58 -0500 | Rating Details | |
2024-10-03 22:52:36 -0500 | Rating Details | |
2024-10-03 22:31:45 -0500 | Rating Details | |
2024-10-03 21:34:13 -0500 | Rating Details | |
2024-10-03 21:30:28 -0500 | Rating Details | |
2024-10-03 21:19:44 -0500 | Rating Details | |
2024-10-03 20:51:55 -0500 | Rating Details | |
2024-10-03 20:26:14 -0500 | Rating Details | |
2024-10-03 20:18:58 -0500 | Rating Details | |
2024-10-03 19:58:38 -0500 | Rating Details | |
2024-10-03 19:58:00 -0500 | Rating Details | |
2024-10-03 19:56:25 -0500 | Rating Details | |
2024-10-03 19:55:05 -0500 | Rating Details | |
2024-10-03 19:52:23 -0500 | Rating Details | |
2024-10-03 19:42:44 -0500 | Rating Details | |
2024-10-07 08:46:24 -0500 | Rating Details | |
2024-10-04 16:33:00 -0500 | Rating Details | |
2024-10-04 14:00:28 -0500 | Rating Details | |
2024-10-04 11:23:40 -0500 | Rating Details | |
2024-10-04 08:46:11 -0500 | Rating Details | |
2024-10-04 08:30:37 -0500 | Rating Details | |
2024-10-04 07:52:38 -0500 | Rating Details | |
2024-10-04 07:39:43 -0500 | Rating Details | |
2024-10-04 04:49:53 -0500 | Rating Details | |
2024-10-04 03:58:29 -0500 | Rating Details | |
2024-10-04 00:26:24 -0500 | Rating Details | |
2024-10-03 22:26:07 -0500 | Rating Details | |
2024-10-03 19:40:45 -0500 | Rating Details | |
2024-10-04 23:35:46 -0500 | Rating Details | |
2024-10-04 13:38:42 -0500 | Rating Details | |
2024-10-04 13:34:58 -0500 | Rating Details | |
2024-10-04 11:42:28 -0500 | Rating Details | |
2024-10-04 10:44:06 -0500 | Rating Details | |
2024-10-04 09:33:42 -0500 | Rating Details | |
2024-10-04 09:10:46 -0500 | Rating Details | |
2024-10-04 08:02:51 -0500 | Rating Details | |
2024-10-04 07:41:54 -0500 | Rating Details | |
2024-10-04 07:33:14 -0500 | Rating Details | |
2024-10-04 04:10:04 -0500 | Rating Details | |
2024-10-04 01:20:45 -0500 | Rating Details | |
2024-10-03 20:02:11 -0500 | Rating Details | |
2024-10-05 06:39:28 -0500 | Rating Details | |
2024-10-04 21:10:32 -0500 | Rating Details | |
2024-10-04 12:30:50 -0500 | Rating Details | |
2024-10-04 12:15:08 -0500 | Rating Details | |
2024-10-04 11:15:19 -0500 | Rating Details | |
2024-10-04 10:05:52 -0500 | Rating Details | |
2024-10-04 09:30:53 -0500 | Rating Details | |
2024-10-04 07:02:29 -0500 | Rating Details | |
2024-10-04 03:49:32 -0500 | Rating Details | |
2024-10-04 01:15:38 -0500 | Rating Details | |
2024-10-04 00:40:47 -0500 | Rating Details | |
2024-10-04 00:15:33 -0500 | Rating Details |